Superagonistic CD28 antibody induces donor-specific tolerance in rat renal allografts

American Journal of Transplantation

Volumn 8, Issue 10, 2008, Pages 2004-2014

  Azuma, H ^a   Isaka, Y ^b   Li, X ^c   Hunig T ^d   Sakamoto, T ^a   Nohmi, H ^a   Takabatake, Y ^b   Mizui, M ^e   Kitazawa, Y ^b   Ichimaru, N ^b   Ibuki, N ^a   Ubai, T ^a   Inamoto, T ^a   Katsuoka, Y ^a   Takahara, S ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

CD28; Regulatory T cell; Tolerance; Transplantation

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY CD28;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; KIDNEY ALLOGRAFT; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; UREMIA;

ANIMALS; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MICE; RATS; RATS, INBRED LEW; RATS, WISTAR; T-LYMPHOCYTES, REGULATORY;

EID: 51849132490     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02358.x     Document Type: Article

References (28)

1. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol 2005 6 : 345 352.
2. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992 71 : 1065 1068.
3. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Ann Rev Immunol 1993 11 : 191 212.
4. Tacke M, Hanke G, Hanke T, Hunig T. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28. Eur J Immunol 1997 27 : 239 247.
5. Dengler TJ, Szabo G, Sido B et al. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Transplantation 1999 67 : 392 398.
6. Beyersdorf N, Gaupp S, Balbach K et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med 2005 202 : 445 455.
7. Luhder F, Huang Y, Dennehy KM et al. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J Exp Med 2003 197 : 955 966.
8. Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 2003 33 : 626 638.
9. Evans EJ, Esnouf RM, Manso-Sancho R et al. Crystal structure of a soluble CD28-Fab complex. Nat Immunol 2005 6 : 271 279.
10. Margulies DH. CD28, costimulator or agonist receptor? J Exp Med 2003 197 : 949 953.
11. Azuma H, Tomita N, Kaneda Y et al. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003 10 : 415 425.
12. Lin H, Bolling SF, Linsley PS et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993 178 : 1801 1806.
13. Eddy AA. Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 1989 135 : 719 733.
14. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004 21 : 267 277.
15. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998 10 : 1969 1980.
16. Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 2004 16 : 1189 1201.
17. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002 168 : 5558 5565.
18. Hunig T. Manipulation of regulatory T-cell number and function with CD28-specific monoclonal antibodies. Adv Immunol 2007 95 : 111 148.
19. Siegmund K, Feuerer M, Siewert C et al. Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005 106 : 3097 3104.
20. Haspot F, Séveno C, Dugast AS et al. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant 2005 5 : 2339 2348.
21. Ford ML, Koehn BH, Wagener ME et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med 2007 204 : 299 309.
22. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A 2003 100 : 8886 8891.
23. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003 198 : 249 258.
24. Suntharalingam G, Perry MR, Ward S et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006 355 : 1018 1028.
25. Stebbings R, Findlay L, Edwards C et al. "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: Better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007 179 : 3325 3331.
26. Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 199 : 1455 1465.
27. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004 199 : 1467 1477.
28. Beyersdorf N, Hanke T, Kerkau T, Hunig T. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann Rheum Dis 2005 64 (Suppl 4 iv91 iv95.